Ashwin Pinto

3.5k total citations
35 papers, 543 citations indexed

About

Ashwin Pinto is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ashwin Pinto has authored 35 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 9 papers in Molecular Biology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ashwin Pinto's work include Myasthenia Gravis and Thymoma (10 papers), Peripheral Neuropathies and Disorders (9 papers) and Ion channel regulation and function (7 papers). Ashwin Pinto is often cited by papers focused on Myasthenia Gravis and Thymoma (10 papers), Peripheral Neuropathies and Disorders (9 papers) and Ion channel regulation and function (7 papers). Ashwin Pinto collaborates with scholars based in United Kingdom, United States and Japan. Ashwin Pinto's co-authors include Bethan Lang, John Newsom–Davis, Joanna Kitley, Lionel Ginsberg, Helen J. Lachmann, Aravinthan Varatharaj, Angela Vincent, Amy Russell, Ian Galea and Liam Carroll and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neurology and Annals of the New York Academy of Sciences.

In The Last Decade

Ashwin Pinto

32 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashwin Pinto United Kingdom 13 320 152 78 67 47 35 543
Tomoko Tanaka United States 12 143 0.4× 65 0.4× 81 1.0× 46 0.7× 100 2.1× 42 501
E Bernard France 15 227 0.7× 107 0.7× 81 1.0× 60 0.9× 21 0.4× 52 563
R Crols Belgium 11 164 0.5× 115 0.8× 52 0.7× 29 0.4× 24 0.5× 27 429
Neeraj Kumar India 12 100 0.3× 152 1.0× 130 1.7× 32 0.5× 67 1.4× 58 478
Michel Melanson Canada 11 162 0.5× 215 1.4× 109 1.4× 16 0.2× 28 0.6× 21 580
Faruk İncecik Türkiye 14 149 0.5× 89 0.6× 65 0.8× 66 1.0× 40 0.9× 86 587
Masanaga Yamawaki Japan 15 159 0.5× 152 1.0× 107 1.4× 52 0.8× 130 2.8× 41 725
R. Gherardi France 15 249 0.8× 62 0.4× 170 2.2× 49 0.7× 82 1.7× 34 577
Reid Longmuir United States 12 173 0.5× 63 0.4× 38 0.5× 38 0.6× 26 0.6× 26 398
Christopher Troedson Australia 13 136 0.4× 147 1.0× 73 0.9× 85 1.3× 31 0.7× 29 524

Countries citing papers authored by Ashwin Pinto

Since Specialization
Citations

This map shows the geographic impact of Ashwin Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwin Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwin Pinto more than expected).

Fields of papers citing papers by Ashwin Pinto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwin Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwin Pinto. The network helps show where Ashwin Pinto may publish in the future.

Co-authorship network of co-authors of Ashwin Pinto

This figure shows the co-authorship network connecting the top 25 collaborators of Ashwin Pinto. A scholar is included among the top collaborators of Ashwin Pinto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashwin Pinto. Ashwin Pinto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinto, Ashwin, et al.. (2025). Transforming care: Patient insights on neurology-led peripheral plasma exchange service. Transfusion and Apheresis Science. 64(3). 104121–104121. 1 indexed citations
2.
Jacob, Saiju, Maria Elena Farrugia, Channa Hewamadduma, et al.. (2025). Association of British Neurologists (ABN) autoimmune myasthenia gravis management guidelines (2025 update). Practical Neurology. 25(5). 422–437. 1 indexed citations
3.
4.
Burke, Georgina, Maria Elena Farrugia, Pablo Garcia-Reitboeck, et al.. (2025). Efgartigimod efficacy and safety in refractory myasthenia gravis: UK’s first real-world experience. Journal of Neurology Neurosurgery & Psychiatry. 96(4). 322–328. 4 indexed citations
5.
Vlaev, Ivo, Ashwin Pinto, Channa Hewamadduma, et al.. (2025). What Patients Don’t Say and Physicians Don’t Ask: A Needs Assessment in Myasthenia Gravis Integrating Patient and Healthcare Professional Perspectives. Neurology and Therapy. 14(4). 1419–1438.
6.
Pinto, Ashwin, et al.. (2022). Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditions. BMC Health Services Research. 22(1). 904–904. 10 indexed citations
7.
Carroll, Liam, Mark Walker, David R. Allen, et al.. (2021). Desminopathy presenting as late onset bilateral facial weakness, with diagnosis supported by lower limb MRI. Neuromuscular Disorders. 31(3). 249–252. 1 indexed citations
8.
Jennings, Rachel, et al.. (2019). 12.18 Neurology led, outpatient plasma exchange: the wessex experience. Journal of Neurology Neurosurgery & Psychiatry. 90(12). e10.1–e10. 1 indexed citations
9.
Rae, William, Joanna Kitley, & Ashwin Pinto. (2018). Selenium Toxicity Associated With Reversible Leukoencephalopathy and Cortical Blindness. JAMA Neurology. 75(10). 1282–1282. 14 indexed citations
10.
Rae, William, Georgina Burke, & Ashwin Pinto. (2016). A study of the utility of azathioprine metabolite testing in myasthenia gravis. Journal of Neuroimmunology. 293. 82–85. 13 indexed citations
11.
Varatharaj, Aravinthan, et al.. (2015). Differential Diagnosis of Finger Drop. The Neurologist. 19(5). 128–131. 3 indexed citations
12.
Kitley, Joanna, Helen J. Lachmann, Ashwin Pinto, & Lionel Ginsberg. (2010). Neurologic manifestations of the cryopyrin-associated periodic syndrome. Neurology. 74(16). 1267–1270. 65 indexed citations
13.
Pinto, Ashwin & Josemir W. Sander. (2003). LEVETIRACETAM: A NEW THERAPEUTIC OPTION FOR REFRACTORY EPILEPSY. International Journal of Clinical Practice. 57(7). 616–621. 8 indexed citations
14.
Lang, Bethan, et al.. (2003). Pathogenic Autoantibodies in the Lambert‐Eaton Myasthenic Syndrome. Annals of the New York Academy of Sciences. 998(1). 187–195. 35 indexed citations
15.
Iwasa, Kazuo, Ashwin Pinto, Angela Vincent, & Bethan Lang. (2003). LEMS IgG Binds to Extracellular Determinants on N‐Type Voltage‐Gated Calcium Channels, but Does Not Reduce VGCC Expression. Annals of the New York Academy of Sciences. 998(1). 196–199. 5 indexed citations
16.
Mäkelä, Petra, et al.. (2002). Recurrent Guillain-Barre Syndrome as a Complication of Immune Reconstitution in HIV. Journal of Infection. 44(1). 47–49. 32 indexed citations
17.
Pinto, Ashwin, Kazuo Iwasa, Claire Newland, John Newsom–Davis, & Bethan Lang. (2002). The action of Lambert–Eaton myasthenic syndrome immunoglobulin G on cloned human voltage‐gated calcium channels. Muscle & Nerve. 25(5). 715–724. 34 indexed citations
18.
Vincent, Angela, Ian R. Hart, Ashwin Pinto, & F. Anne Stephenson. (1999). [36] Antibodies to ion channels. Methods in enzymology on CD-ROM/Methods in enzymology. 294. 677–704. 1 indexed citations
19.
Pinto, Ashwin, Fraser J. Moss, Bethan Lang, et al.. (1998). Differential Effect of Lambert‐Eaton Myasthenic Syndrome Immunoglobulin on Cloned Neuronal Voltage‐gated Calcium Channelsa. Annals of the New York Academy of Sciences. 841(1). 687–690. 8 indexed citations
20.
Lang, Bethan, Sally A. Waterman, Ashwin Pinto, et al.. (1998). The Role of Autoantibodies in Lambert‐Eaton Myasthenic Syndromeaa. Annals of the New York Academy of Sciences. 841(1). 596–605. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomoko Tanaka Breakdown of academic impact, for papers by E Bernard Breakdown of academic impact, for papers by R Crols Breakdown of academic impact, for papers by Neeraj Kumar Breakdown of academic impact, for papers by Michel Melanson Breakdown of academic impact, for papers by Faruk İncecik Breakdown of academic impact, for papers by Masanaga Yamawaki Breakdown of academic impact, for papers by R. Gherardi Breakdown of academic impact, for papers by Reid Longmuir Breakdown of academic impact, for papers by Christopher Troedson
Rankless by CCL
2026